United Therapeutics (UTHR) Tops Q1 EPS by $1.69
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $501.27 -2.04%
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $5.03, $1.69 better than the analyst estimate of $3.34. Revenue for the quarter came in at $461.9 million versus the consensus estimate of $420.02 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- Hitachi Ltd. (HIT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
